Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: Correlation with structure and epitope prediction

Journal of Virology

Volumn 88, Issue 14, 2014, Pages 7828-7842

  Schwaiger, Julia ^a   Aberle, Judith H ^a   Stiasny, Karin ^a   Knapp, Bernhard ^a,b   Schreiner, Wolfgang ^a   Fae, Ingrid ^a   Fischer, Gottfried ^a   Scheinost, Ondrej ^c   Chmelik, Vaclav ^c   Heinz, Franz X ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Hospital Ceske Budejovice   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; E PROTEIN; EPITOPE; INACTIVATED VIRUS VACCINE; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; PEPTIDE DERIVATIVE; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; AGED; ALPHA HELIX; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES; FEMALE; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; PROTEIN CONFORMATION; VACCINES, INACTIVATED; VIRAL VACCINES; YOUNG ADULT;

EID: 84904685791     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00196-14     Document Type: Article

References (84)

1. Pierson TC, Diamond MS. 2013. Flaviviruses, p 747-794. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Rancaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Pierson TC, Diamond MS. 2008. Molecular mechanisms of antibodymediated neutralisation of flavivirus infection. Expert Rev. Mol. Med. 10:e12. http://dx.doi.org/10.1017/S1462399408000665.
3. Pierson TC, Fremont DH, Kuhn RJ, Diamond MS. 2008. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4:229-238. http://dx.doi.org/10.1016/j.chom.2008.08.004.
4. + T cells in immunity to viruses. Nat. Rev. Immunol. 12:136-148. http://dx.doi.org/10.1038/nri3152.
5. + T cells in viral immunity. J. Exp. Med. 209:1391-1395. http://dx.doi.org/10.1084/jem.20121517.
6. Vyas JM, Van der Veen AG, Ploegh HL. 2008. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 8:607-618. http://dx.doi.org/10.1038/nri2368.
7. Hsing LC, Rudensky AY. 2005. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207:229-241. http://dx.doi.org/10.1111/j.0105-2896.2005.00310.x.
8. Neefjes J, Jongsma ML, Paul P, Bakke O. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11:823-836. http://dx.doi.org/10.1038/nri3084.
9. Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SG. 2013. The IMGT/HLA database. Nucleic Acids Res. 41:D1222-D1227. http://dx.doi.org/10.1093/nar/gks949.
10. Corse E, Gottschalk RA, Allison JP. 2011. Strength of TCR-peptide/MHC interactions and in vivo T cell responses. J. Immunol. 186:5039-5045. http://dx.doi.org/10.4049/jimmunol.1003650.
11. Baumgartner CK, Malherbe LP. 2011. Antigen-driven T-cell repertoire selection during adaptive immune responses. Immunol. Cell Biol. 89:54-59. http://dx.doi.org/10.1038/icb.2010.117.
12. Sant AJ, Chaves FA, Krafcik FR, Lazarski CA, Menges P, Richards K, Weaver JM. 2007. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design. Expert Rev. Vaccines 6:357-368. http://dx.doi.org/10.1586/14760584.6.3.357.
13. Baumgartner CK, Malherbe LP. 2010. Regulation of CD4 T-cell receptor diversity by vaccine adjuvants. Immunology 130:16-22. http://dx.doi.org /10.1111/j.1365-2567.2010.03265.x.
14. Scherle PA, Gerhard W. 1986. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J. Exp. Med. 164:1114-1128.
15. Scherle PA, Gerhard W. 1988. Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Proc. Natl. Acad. Sci. U. S. A. 85:4446-4450. http://dx.doi.org/10.1073/pnas.85.12.4446.
16. Russell SM, Liew FY. 1979. T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature 280:147-148. http://dx.doi.org/10.1038/280147a0.
17. Milich DR, McLachlan A, Thornton GB, Hughes JL. 1987. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329:547-549. http://dx.doi.org/10.1038/329547a0.
18. Fischer A, Nash S, Beverley PC, Feldmann M. 1982. An influenza virus matrix protein-specific human T cell line with helper activity for in vitro anti-hemagglutinin antibody production. Eur. J. Immunol. 12:844-849. http://dx.doi.org/10.1002/eji.1830121009.
19. Bryson CJ, Jones TD, Baker MP. 2010. Prediction of immunogenicity of therapeutic proteins: validity of computational tools. BioDrugs 24:1-8. http://dx.doi.org/10.2165/11318560-000000000-00000.
20. Heinz FX, Stiasny K. 2012. Flaviviruses and their antigenic structure. J. Clin. Virol. 55:289-295. http://dx.doi.org/10.1016/j.jcv.2012.08.024.
21. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. 2003. Structure of West Nile virus. Science 302:248. http://dx.doi.org/10.1126/science.1089316.
22. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717-725. http://dx.doi.org /10.1016/S0092-8674(02)00660-8.
23. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-298. http://dx.doi.org/10.1038/375291a0.
24. Dokland T, Walsh M, Mackenzie JM, Khromykh AA, Ee KH, Wang S. 2004. West Nile virus core protein; tetramer structure and ribbon formation. Structure 12:1157-1163. http://dx.doi.org/10.1016/j.str.2004.04.024.
25. Anthony DD, Lehmann PV. 2003. T-cell epitope mapping using the ELISPOT approach. Methods 29:260-269. http://dx.doi.org/10.1016 /S1046-2023(02)00348-1.
26. Richards KA, Chaves FA, Krafcik FR, Topham DJ, Lazarski CA, Sant AJ. 2007. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLADR1-restricted CD4 T-cell response to influenza virus hemagglutinin. J. Virol. 81:7608-7619. http://dx.doi.org/10.1128/JVI.02834-06.
27. Nayak JL, Richards KA, Chaves FA, Sant AJ. 2010. Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. Viral Immunol. 23:169-180. http://dx.doi.org/10.1089/vim.2009.0099.
28. Stiasny K, Aberle JH, Chmelik V, Karrer U, Holzmann H, Heinz FX. 2012. Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis. J. Clin. Virol. 54:115-120. http://dx.doi.org/10.1016/j.jcv.2012.02.016.
29. Stiasny K, Holzmann H, Heinz FX. 2009. Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine 27:7021-7026. http://dx.doi.org/10.1016/j.vaccine.2009.09.069.
30. Kiermayr S, Kofler RM, Mandl CW, Messner P, Heinz FX. 2004. Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles. J. Virol. 78:8078-8084. http://dx.doi.org/10.1128/JVI.78.15.8078-8084.2004.
31. Heinz FX, Kunz C. 1981. Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J. Gen. Virol. 57:263-274. http://dx.doi.org/10.1099 /0022-1317-57-2-263.
32. Laemmli UK, Favre M. 1973. Maturation of the head of bacteriophage T4. I. DNA packaging events. J. Mol. Biol. 80:575-599.
33. Schaffner W, Weissmann C. 1973. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56: 502-514. http://dx.doi.org/10.1016/0003-2697(73)90217-0.
34. Zhang X, Ge P, Yu X, Brannan JM, Bi G, Zhang Q, Schein S, Zhou ZH. 2013. Cryo-EM structure of the mature dengue virus at 3.5-Å resolution. Nat. Struct. Mol. Biol. 20:105-110. http://dx.doi.org/10.1038/nsmb.2463.
35. Ludajic K, Fae I, Fischer GF. 2006. Characterization of a new HLA-DPB1 allele, DPB1*010103. Tissue Antigens 67:255-256. http://dx.doi.org/10.1111/j.1399-0039.2006.00554.x.
36. Fischer GF, Fae I, Petrasek M, Haas H, Mayr WR. 1995. An HLA-DR11 variant (HLA-DRB1*1115) segregating in a family of Turkish origin. Tissue Antigens 45:143-144. http://dx.doi.org/10.1111/j.1399-0039.1995.tb02432.x.
37. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B. 2008. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4:e1000048. http://dx.doi.org /10.1371/journal.pcbi.1000048.
38. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B. 2010. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11:568. http://dx.doi.org/10.1186/1471-2105-11-568.
39. Knapp B, Giczi V, Ribarics R, Schreiner W. 2011. PeptX: using genetic algorithms to optimize peptides for MHC binding. BMC Bioinformatics 12:241. http://dx.doi.org/10.1186/1471-2105-12-241.
40. Gelder CM, Welsh KI, Faith A, Lamb JR, Askonas BA. 1995. Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection. J. Virol. 69:7497-7506.
41. Aberle JH, Stiasny K, Kundi M, Heinz FX. 2013. Mechanistic insights into the impairment of memory B cells and antibody production in the elderly. Age (Dordr.) 35:371-381. http://dx.doi.org/10.1007/s11357-011-9371-9.
42. Litjens NH, Huisman M, Hijdra D, Lambrecht BM, Stittelaar KJ, Betjes MG. 2008. IL-2 producing memory CD4+ T lymphocytes are closely associated with the generation of IgG-secreting plasma cells. J. Immunol. 181:3665-3673. http://dx.doi.org/10.4049/jimmunol.181.5.3665.
43. Landry SJ. 2008. Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin. J. Virol. 82:1238-1248. http://dx.doi.org/10.1128/JVI.02026-07.
44. Carmicle S, Steede NK, Landry SJ. 2007. Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes. Mol. Immunol. 44:1159-1168. http://dx.doi.org/10.1016/j.molimm.2006.06.014.
45. + T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc. Natl. Acad. Sci. U. S. A. 98:4587-4592. http://dx.doi.org/10.1073/pnas.071063898.
46. Brown SA, Stambas J, Zhan X, Slobod KS, Coleclough C, Zirkel A, Surman S, White SW, Doherty PC, Hurwitz JL. 2003. Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity. J. Immunol. 171:4140-4148. http://dx.doi.org/10.4049 /jimmunol.171.8.4140.
47. + T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. J. Viral Hepat. 11:324-331. http://dx.doi.org/10.1111/j.1365-2893.2004.00516.x.
48. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, Mbawuike IN, Alexander J, Newman MJ, Grey H, Sette A. 2008. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J. Virol. 82:12241-12251. http://dx.doi.org/10.1128/JVI.01563-08.
49. + T cell memory to lymphocytic choriomeningitis virus infection. J. Virol. 85:11770-11780. http://dx.doi.org/10.1128/JVI.05477-11.
50. Pajot A, Michel ML, Mancini-Bourgine M, Ungeheuer MN, Ojcius DM, Deng Q, Lemonnier FA, Lone YC. 2006. Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects. Microbes Infect. 8:2783-2790. http://dx.doi.org/10.1016/j.micinf.2006.08.009.
51. Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E. 2009. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Vaccine 27:5393-5401. http://dx.doi.org/10.1016/j.vaccine.2009.06.081.
52. + T cell epitopes from vaccinia virus induced by vaccination or infection. PLoS Pathog. 3:1511-1529. http://dx.doi.org/10.1371/journal.ppat.0030144.
53. + Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J. Virol. 77:9463-9473. http://dx.doi.org/10.1128/JVI.77.17.9463-9473.2003.
54. Lindenbach BD, Murray CL, Thiel HJ, Rice CM. 2013. Flaviviridae, p 712-746. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Rancaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
55. + T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 112:2017-2027. http://dx.doi.org/10.1053/gast.1997.v112.pm9178695.
56. Min WP, Kamikawaji N, Mineta M, Tana T, Kashiwagi S, Sasazuki T. 1996. Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans. Hum. Immunol. 46:93-99. http://dx.doi.org/10.1016/0198-8859(96)00009-2.
57. Desombere I, Gijbels Y, Verwulgen A, Leroux-Roels G. 2000. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines. Clin. Exp. Immunol. 122:390-399. http://dx.doi.org/10.1046/j.1365-2249.2000.01383.x.
58. Doh H, Roh S, Lee KW, Kim K. 2003. Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes. FEMS Immunol. Med. Microbiol. 35: 77-85. http://dx.doi.org/10.1016/S0928-8244(02)00461-3.
59. + T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. Int. Immunol. 25:447-457. http://dx.doi.org/10.1093/intimm/dxt005.
60. + T-cell recognition of influenza A virus hemagglutinin after subunit vaccination. J. Virol. 70:4787-4790.
61. + T cell response to the vaccinia protective antigens B5R and A33R. Mol. Immunol. 46:1481-1487. http://dx.doi.org/10.1016/j.molimm.2008.12.016.
62. Kennedy RB, Poland GA. 2010. The identification of HLA class IIrestricted T cell epitopes to vaccinia virus membrane proteins. Virology 408:232-240. http://dx.doi.org/10.1016/j.virol.2010.09.013.
63. Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, Tang X, Temperton NJ, Weiss RA, Brenchley JM, Douek DC, Mongkolsapaya J, Tran BH, Lin CL, Screaton GR, Hou JL, McMichael AJ, Xu XN. 2008. T cell responses to whole SARS coronavirus in humans. J. Immunol. 181:5490-5500. http: //dx.doi.org/10.4049/jimmunol.181.8.5490.
64. + memory T-lymphocyte responses to SARS coronavirus infection. Virology 368:317-321. http://dx.doi.org/10.1016/j.virol.2007.07.015.
65. + cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J. Virol. 82:11792-11802. http://dx.doi.org/10.1128/JVI.00692-08.
66. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, Johnston MN, Corcoran C, Wurcel AG, Fitzpatrick CA, Feeney ME, Rodriguez WR, Basgoz N, Draenert R, Stone DR, Brander C, Goulder PJ, Rosenberg ES, Altfeld M, Walker BD. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77:2081-2092. http://dx.doi.org/10.1128/JVI.77.3.2081-2092.2003.
67. + T cell responses that recognize structural and nonstructural proteins. J. Virol. 87: 12794-12804. http://dx.doi.org/10.1128/JVI.01160-13.
68. + T lymphocytes in dengue virus infection. J. Virol. 87:2693-2706. http://dx.doi.org/10.1128/JVI.02675-12.
69. + cells. J. Immunol. 183:7860-7869. http://dx.doi.org/10.4049/jimmunol.0902276.
70. McKee AS, Burchill MA, Munks MW, Jin L, Kappler JW, Friedman RS, Jacobelli J, Marrack P. 2013. Host DNA released in response to aluminum adjuvant enhancesMHCclass II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 110:E1122-E1131. http://dx.doi.org/10.1073/pnas.1300392110.
71. Marichal T, Ohata K, Bedoret D, Mesnil C, Sabatel C, Kobiyama K, Lekeux P, Coban C, Akira S, Ishii KJ, Bureau F, Desmet CJ. 2011. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med. 17:996-1002. http://dx.doi.org/10.1038/nm.2403.
72. Labuda M, Austyn JM, Zuffova E, Kozuch O, Fuchsberger N, Lysy J, Nuttall PA. 1996. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 219:357-366. http://dx.doi.org /10.1006/viro.1996.0261.
73. Eisenlohr LC, Luckashenak N, Apcher S, Miller MA, Sinnathamby G. 2011. Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways. Immunol. Res. 51:237-248. http://dx.doi.org/10.1007/s12026-011-8257-3.
74. Metz B, Kersten GF, Hoogerhout P, Brugghe HF, Timmermans HA, de Jong A, Meiring H, ten Hove J, Hennink WE, Crommelin DJ, Jiskoot W. 2004. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J. Biol. Chem. 279:6235-6243. http: //dx.doi.org/10.1074/jbc.M310752200.
75. Zlatkovic J, Tsouchnikas G, Jarmer J, Koessl C, Stiasny K, Heinz FX. 2013. Aluminum hydroxide influences not only extent but also fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice. J. Virol. 87:12187-12195. http://dx.doi.org/10.1128 /JVI.01690-13.
76. Stiasny K, Fritz R, Pangerl K, Heinz FX. 2011. Molecular mechanisms of flavivirus membrane fusion. Amino Acids 41:1159-1163. http://dx.doi.org/10.1007/s00726-009-0370-4.
77. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA. 2004. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23:728-738. http://dx.doi.org/10.1038/sj.emboj.7600064.
78. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. 1995. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 181:1957-1963. http://dx.doi.org/10.1084/jem.181.6.1957.
79. Antoniou AN, Watts C. 2002. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of Fc RII. Eur. J. Immunol. 32:530-540. http://dx.doi.org/10.1002/1521-4141(200202)32:2<530::AID-IMM U530>3.0.CO;2-X.
80. Hughes HR, Crill WD, Davis BS, Chang GJ. 2012. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines. Virology 424:129-137. http://dx.doi.org/10.1016/j.virol.2011.12.012.
81. Prange R, Streeck RE. 1995. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J. 14:247-256.
82. Bruss V. 2004. Envelopment of the hepatitis B virus nucleocapsid. Virus Res. 106:199-209. http://dx.doi.org/10.1016/j.virusres.2004.08.016.
83. Dimitrov I, Garnev P, Flower DR, Doytchinova I. 2010. MHC class II binding prediction-a little help from a friend. J. Biomed. Biotechnol. 2010:705821. http://dx.doi.org/10.1155/2010/705821.
84. Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, Roggendorf M, Roggendorf H, Allwinn R, Heinz FX. 2013. Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog. 9:e1003458. http://dx.doi.org/10.1371/journal.ppat.1003458.